The role of iron in neurodegenerative disorders: Insights and opportunities with synchrotron light

Frontiers in Pharmacology

Volumn 5 AUG, Issue , 2014, Pages

  Collingwood, Joanna F ^a,b   Davidson, Mark R ^b,c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b J Crayton Pruitt Family Department of Biomedical Engineering   (United States)

^c The Tech Toybox   (United States)

Author keywords

Alzheimer's disease; Amyloid aggregation; Human brain; Iron; Magnetic resonance imaging; Neuromelanin; Parkinson's disease; Synchrotron X rays

Indexed keywords

FERRITIN; HEMOGLOBIN; TRANSFERRIN;

ABSORPTION SPECTROSCOPY; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; FRIEDREICH ATAXIA; HUMAN; IRON METABOLISM; LIMIT OF DETECTION; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN AGGREGATION; REVIEW; SENSITIVITY AND SPECIFICITY; SYNCHROTRON; X RAY ABSORPTION SPECTROSCOPY; X RAY FLUORESCENCE;

EID: 84906769907     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00191     Document Type: Review

References (110)

1. Antharam, V., Collingwood, J. F., Bullivant, J. P., Davidson, M. R., Chandra, S., Mikhaylova, A.,et al. (2012). High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron. Neuroimage 59, 1249-1260. doi: 10.1016/j.neuroimage.2011.08.019
2. Ascone, I., and Strange, R. (2009). Biological X-ray absorption spectroscopy and metalloproteomics. J. Synchrotron Radiat. 16, 413-421. doi: 10.1107/S0909049509010425
3. Bacquart, T., Deves, G., Carmona, A., Tucoulou, R., Bohic, S., and Ortega, R. (2007). Subcellular speciation analysis of trace element oxidation states using synchrotron radiation micro-X-ray absorption near-edge structure. Anal. Chem. 79, 7353-7359. doi: 10.1021/ac0711135
4. Blazejewska, A. I., Schwarz, S. T., Pitiot, A., Stephenson, M. C., Lowe, J., Bajaj, N.,et al. (2013). Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology 81, 534-540. doi: 10.1212/WNL.0b013e31829e6fd2
5. Bohic, S., Murphy, K., Paulus, W., Cloetens, P., Salome, M., Susini, J.,et al. (2008). Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron X-ray microspectroscopy. Anal. Chem. 80, 9557-9566. doi: 10.1021/ac801817k
6. Booyjzsen, C., Scarff, C. A., Moreton, B., Portman, I., Scrivens, J. H., Costantini, G.,et al. (2012). Fibrillation of transferrin. Biochim. Biophys. Acta 1820, 427-436. doi: 10.1016/j.bbagen.2011.11.004
7. Bourgeois, D., Vallone, B., Schotte, F., Arcovito, A., Miele, A. E., Sciara, G.,et al. (2003). Complex landscape of protein structural dynamics unveiled by nanosecond Laue crystallography. Proc. Natl. Acad. Sci. U.S.A. 100, 8704-8709. doi: 10.1073/pnas.1430900100
8. Campanella, A., Rovelli, E., Santambrogio, P., Cozzi, A., Taroni, F., and Levi, S. (2009). Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. Hum. Mol. Genet. 18, 1-11. doi: 10.1093/hmg/ddn308
9. Carmona, A., Deves, G., Roudeau, S., Cloetens, P., Bohic, S., and Ortega, R. (2010). Manganese accumulates within Golgi apparatus in dopaminergic cells as revealed by synchrotron X-ray fluorescence nanoimaging. ACS Chem. Neurosci. 1, 194-203. doi: 10.1021/cn900021z
10. Carter, E. A., Rayner, B. S., Mcleod, A. I., Wu, L. E., Marshall, C. P., Levina, A.,et al. (2010). Silicon nitride as a versatile growth substrate for microspectroscopic imaging and mapping of individual cells. Mol. Biosyst. 6, 1316-1322. doi: 10.1039/c001499k
11. Castellani, R. J., Moreira, P. I., Liu, G., Dobson, J., Perry, G., Smith, M. A.,et al. (2007). Iron: the Redox-active center of oxidative stress in Alzheimer disease. Neurochem. Res. 32, 1640-1645. doi: 10.1007/s11064-007-9360-9367
12. Castellano, A. C., Barteri, M., Bianconi, A., Borghi, E., Cassiano, L., Castagnola, M.,et al. (1993). X-ray small angle scattering of the human transferrin protein aggregates. A fractal study.Biophys. J. 64, 520-524. doi: 10.1016/S0006-3495(93)81394-81398
13. Chwiej, J., Adamek, D., Szczerbowska-Boruchowska, M., Krygowska-Wajs, A., Wojcik, S., Falkenberg, G.,et al. (2007). Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique. J. Biol. Inorg. Chem. 12, 204-211. doi: 10.1007/s00775-006-0179-175
14. Collingwood, J. F., Chandra, S., Davidson, M., Mikhaylova, A., Eskin, T., Dobson, J.,et al. (2008a). High-resolution magnetic resonance imaging to quantify relaxation parameters in Alzheimer's brain tissue. Alzheimers Dement. 4 (suppl.), T365-T366. doi: 10.1016/j.jalz.2008.05.1081
15. Collingwood, J. F., Chong, R. K., Kasama, T., Cervera-Gontard, L., Dunin-Borkowski, R. E., Perry, G.,et al. (2008b). Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J. Alzheimers Dis. 14, 235-245.
16. Collingwood, J. F., Mikhaylova, A., Davidson, M., Batich, C., Streit, W. J., Terry, J.,et al. (2005a). In situ characterization and mapping of iron compounds in Alzheimer's disease tissue. J. Alzheimers Dis. 7, 267-272.
17. Collingwood, J. F., Mikhaylova, A., Davidson, M. R., Batich, C., Streit, W. J., Eskin, T.,et al. (2005b). High-resolution x-ray absorption spectroscopy studies of metal compounds in neurodegenerative brain tissue. J. Phys. Conf. Ser . 17, 54-60. doi: 10.1088/1742-6596/17/1/009
18. Cook, J. D., Penner-Hahn, J. E., and Stemmler, T. L. (2008). Structure and dynamics of metalloproteins in live cells. Methods Cell Biol. 90, 199-216. doi: 10.1016/S0091-679X(08)00810-818
19. Crichton, R. R., Dexter, D., and Ward, R. (2011). Brain iron metabolism and its pertubation in neurological diseases. J. Neural Transm. 118, 301-314. doi: 10.1007/s00702-010-0470-z
20. Currie, L. A. (1968). Limits for qualitative detection and quantitative determination: application to radiochemistry. Anal. Chem. 40, 586-593. doi: 10.1021/ac60259a007
21. Davies, P., Moualla, D., and Brown, D. R. (2011). Alpha-synuclein is a cellular ferrireductase. PLoS ONE 6:e15814. doi: 10.1371/journal.pone.0015814
22. De Stasio, G., Dunham, D., Tonner, B. P., Mercanti, D., Ciotti, M. T., Perfetti, P.,et al. (1995). Application of photoelectron spectromicroscopy to a systematic study of toxic and natural elements in neurons. J. Synchrotron Radiat. 2, 106-112. doi: 10.1107/S0909049594012744
23. Devos, D., Moreau, C., Devedjian, J. C., Kluza, J., Petrault, M., Laloux, C.,et al. (2014). Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid. Redox Signal. 21, 195-210. doi: 10.1089/ars.2013.5593
24. Dexter, D. T., Wells, F. R., Lees, A. J., Agid, F., Agid, Y., Jenner, P.,et al. (1989). Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52, 1830-1836. doi: 10.1111/j.1471-4159.1989.tb07264.x
25. Double, K. L., Gerlach, M., Schunemann, V., Trautwein, A. X., Zecca, L., Gallorini, M.,et al. (2003). Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem. Pharmacol. 66, 489-494. doi: 10.1016/S0006-2952(03)00293-4
26. Drayer, B., Burger, P., Darwin, R., Riederer, S., Herfkens, R., and Johnson, G. A. (1986). MRI of brain iron. AJR Am. J. Roentgenol. 147, 103-110. doi: 10.2214/ajr.147.1.103
27. Duke, E. M. H., and Johnson, L. N. (2010). Macromolecular crystallography at synchrotron radiation sources: current status and future developments. Proc. R. Soc. A. 466, 3421-3452. doi: 10.1098/rspa.2010.0448
28. Dunn, J. R., Fuller, M., Zoeger, J., Dobson, J., Heller, F., Hammann, J.,et al. (1995). Magnetic material in the human hippocampus. Brain Res. Bull. 36, 149-153. doi: 10.1016/0361-9230(94)00182-Z
29. Earle, K. M. (1968). Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. J. Neuropathol. Exp. Neurol. 27, 1-14. doi: 10.1097/00005072-196801000-00001
30. Einsle, O., Andrade, S. L., Dobbek, H., Meyer, J., and Rees, D. C. (2007). Assignment of individual metal redox states in a metalloprotein by crystallographic refinement at multiple X-ray wavelengths. J. Am. Chem. Soc. 129, 2210-2211. doi: 10.1021/ja067562o
31. Ektessabi, A., Yoshida, S., and Takada, T. (1999). Distribution of iron in a single neuron of patients with Parkinson's disease. X-Ray Spectrom. 28, 456-460. doi: 10.1002/(SICI)1097-4539(199911/12)28:6<456::AID-XRS392>3.0.CO;2-C
32. Everett, J., Cespedes, E., Shelford, L. R., Exley, C., Collingwood, J. F., Dobson, J.,et al. (2014a). Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide beta-amyloid. Inorg. Chem. 53, 2803-2809. doi: 10.1021/ic402406g
33. Everett, J., Cespedes, E., Shelford, L. R., Exley, C., Collingwood, J. F., Dobson, J.,et al. (2014b). Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide beta-amyloid (1-42). J. R. Soc. Interface 11:20140165. doi: 10.1098/rsif.2014.0165
34. Exley, C., House, E., Collingwood, J. F., Davidson, M. R., Cannon, D., and Donald, A. M. (2010). Spherulites of amyloid-beta42 in vitro and in Alzheimer's disease. J. Alzheimers Dis. 20, 1159-1165. doi: 10.3233/JAD-2010-091630
35. Exley, C., House, E., Polwart, A., and Esiri, M. M. (2012). Brain burdens of aluminum, iron, and copper and their relationships with amyloid-beta pathology in 60 human brains. J. Alzheimers Dis. 31, 725-730. doi: 10.3233/JAD-2012-120766
36. Flinn, J. M., Hunter, D., Linkous, D. H., Lanzirotti, A., Smith, L. N., Brightwell, J.,et al. (2005). Enhanced zinc consumption causes memory deficits and increased brain levels of zinc. Physiol. Behav. 83, 793-803. doi: 10.1016/j.physbeh.2004.10.009
37. Friedman, A., Galazka-Friedman, J., and Koziorowski, D. (2009). Iron as a cause of Parkinson disease - a myth or a well established hypothesis? Parkinsonism Relat. Disord . 15S3, S212-S214. doi: 10.1016/S1353-8020(09)70817-X
38. Galazka-Friedman, J., Bauminger, E. R., Friedman, A., Barcikowska, M., Hechel, D., and Nowik, I. (1996). Iron in parkinsonian and control substantia nigra-a Mossbauer spectroscopy study. Mov. Disord. 11, 8-16. doi: 10.1002/mds.870110104
39. Gallagher, J. J., Finnegan, M. E., Grehan, B., Dobson, J., Collingwood, J. F., and Lynch, M. A. (2012). Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress. J. Alzheimers Dis. 28, 147-161. doi: 10.3233/JAD-2011-110614
40. George, G. N., Pickering, I. J., Pushie, M. J., Nienaber, K., Hackett, M. J., Ascone, I.,et al. (2012). X-ray-induced photo-chemistry and X-ray absorption spectroscopy of biological samples. J. Synchrotron Radiat. 19, 875-886. doi: 10.1107/S090904951203943X
41. Geraki, K., Farquharson, M. J., and Bradley, D. A. (2002). Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study. Phys. Med. Biol. 47, 2327-2339. doi: 10.1088/0031-9155/47/13/310
42. Gerlach, M., Ben-Shachar, D., Riederer, P., and Youdim, M. B. (1994). Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem . 63, 793-807. doi: 10.1046/j.1471-4159.1994.63030793.x
43. Gerlach, M., Trautwein, A. X., Zecca, L., Youdim, M. B., and Riederer, P. (1995). Mossbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra. J. Neurochem. 65, 923-926. doi: 10.1046/j.1471-4159.1995.65020923.x
44. Griffiths, P. D., Dobson, B. R., Jones, G. R., and Clarke, D. T. (1999). Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy.Brain 122(Pt 4), 667-673. doi: 10.1093/brain/122.4.667
45. Hasnain, S. S. (2004). Synchrotron techniques for metalloproteins and human disease in post genome era. J. Synchrotron Radiat. 11, 7-11. doi: 10.1107/S0909049503024166
46. Hautot, D., Pankhurst, Q. A., Khan, N., and Dobson, J. (2003). Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue. Proc. Biol. Sci. 270(Suppl. 1), S62-S64. doi: 10.1098/rsbl.2003.0012
47. Hopp, K., Popescu, B. F., Mccrea, R. P., Harder, S. L., Robinson, C. A., Haacke, M. E.,et al. (2010). Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence. J. Magn. Reson. Imaging 31, 1346-1354. doi: 10.1002/jmri.22201
48. House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., and Exley, C. (2004). Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J. Alzheimers Dis. 6, 291-301.
49. House, E., Jones, K., and Exley, C. (2011). Spherulites in human brain tissue are composed of beta sheets of amyloid and resemble senile plaques. J. Alzheimers Dis. 25, 43-46. doi: 10.3233/JAD-2011-110071
50. House, E., Mold, M., Collingwood, J., Baldwin, A., Goodwin, S., and Exley, C. (2009). Copper abolishes the beta-sheet secondary structure of preformed amyloid fibrils of amyloid-beta(42). J. Alzheimers Dis. 18, 811-817. doi: 10.3233/JAD-2009-1235
51. House, M. J., St Pierre, T. G., and Mclean, C. (2008). 1.4T study of proton magnetic relaxation rates, iron concentrations, and plaque burden in Alzheimer's disease and control postmortem brain tissue. Magn. Reson. Med. 60, 41-52. doi: 10.1002/mrm.21586
52. Ince, P. G., Shaw, P. J., Candy, J. M., Mantle, D., Tandon, L., Ehmann, W. D.,et al. (1994). Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci. Lett. 182, 87-90. doi: 10.1016/0304-3940(94)90213-5
53. Ishihara, R., Ide-Ektessabi, A., Ikeda, K., Mizuno, Y., Fujisawa, S., Takeuchi, T.,et al. (2002). Investigation of cellular metallic elements in single neurons of human brain tissues. Neuroreport 13, 1817-1820. doi: 10.1097/00001756-200210070-00026
54. Jackson, B., Harper, S., Smith, L., and Flinn, J. (2006). Elemental mapping and quantitative analysis of Cu, Zn, and Fe in rat brain sections by laser ablation ICP-MS. Anal. Bioanal. Chem. 384, 951-957. doi: 10.1007/s00216-005-0264-266
55. Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben-Shachar, D.,et al. (1992). Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis. J. Neurochem. 59, 1168-1171. doi: 10.1111/j.1471-4159.1992.tb08362.x
56. Jenner, P. (1989). Clues to the mechanism underlying dopamine cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 52(Suppl. 22), 22-28. doi: 10.1136/jnnp.52.Suppl.22
57. Kastyak, M. Z., Szczerbowska-Boruchowska, M., Adamek, D., Tomik, B., Lankosz, M., and Gough, K. M. (2010). Pigmented creatine deposits in amyotrophic lateral sclerosis central nervous system tissues identified by synchrotron Fourier transform infrared microspectroscopy and X-ray fluorescence spectromicroscopy. Neuroscience 166, 1119-1128. doi: 10.1016/j.neuroscience.2010.01.017
58. Kell, D. B. (2010). Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol. 84, 825-889. doi: 10.1007/s00204-010-0577-x
59. Khan, A., Dobson, J. P., and Exley, C. (2006). Redox cycling of iron by Abeta42. Free Radic. Biol. Med. 40, 557-569. doi: 10.1016/j.freeradbiomed.2005.09.013
60. Kim, M., Rho, Y., Jin, K. S., Ahn, B., Jung, S., Kim, H.,et al. (2011). pH-dependent structures of ferritin and apoferritin in solution: disassembly and reassembly. Biomacromolecules 12, 1629-1640. doi: 10.1021/bm200026v
61. Kirschvink, J. L., Kobayashi-Kirschvink, A., and Woodford, B. J. (1992). Magnetite biomineralization in the human brain. Proc. Natl. Acad. Sci. U.S.A. 89, 7683-7687. doi: 10.1073/pnas.89.16.7683
62. Kosior, E., Bohic, S., Suhonen, H., Ortega, R., Deves, G., Carmona, A.,et al. (2012). Combined use of hard X-ray phase contrast imaging and X-ray fluorescence microscopy for sub-cellular metal quantification. J. Struct. Biol. 177, 239-247. doi: 10.1016/j.jsb.2011.12.005
63. Kropf, A. J., Bunker, B. A., Eisner, M., Moss, S. C., Zecca, L., Stroppolo, A.,et al. (1998). X-ray absorption fine-structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues. Biophys. J. 75, 3135-3142. doi: 10.1016/S0006-3495(98)77755-77750
64. Leskovjan, A. C., Kretlow, A., Lanzirotti, A., Barrea, R., Vogt, S., and Miller, L. M. (2011). Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease. Neuroimage 55, 32-38. doi: 10.1016/j.neuroimage.2010.11.073
65. Leskovjan, A. C., Lanzirotti, A., and Miller, L. M. (2009). Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease. Neuroimage 47, 1215-1220. doi: 10.1016/j.neuroimage.2009.05.063
66. Levi, S., Corsi, B., Bosisio, M., Invernizzi, R., Volz, A., Sanford, D.,et al. (2001). A human mitochondrial ferritin encoded by an intronless gene. J. Biol. Chem. 276, 24437-24440. doi: 10.1074/jbc.C100141200
67. Lhermitte, J., Kraus, W. M., and Mcalpine, D. (1924). Original papers: on the occurrence of abnormal deposits of iron in the brain in parkinsonism with special reference to its localisation. J. Neurol. Psychopathol. 5, 195-208. doi: 10.1136/jnnp.s1-5.19.195
68. Li, J., Uversky, V. N., and Fink, A. L. (2001). Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 40, 11604-11613. doi: 10.1021/bi010616g
69. Lima, F. A., Milne, C. J., Amarasinghe, D. C., Rittmann-Frank, M. H., Van Der Veen, R. M., Reinhard, M.,et al. (2011). A high-repetition rate scheme for synchrotron-based picosecond laser pump/x-ray probe experiments on chemical and biological systems in solution. Rev. Sci. Instrum. 82, 063111. doi: 10.1063/1.3600616
70. Lobinski, R., Becker, J. S., Haraguchi, H., and Sarkar, B. (2010). Metallomics: guidelines for terminology and critical evaluation of analytical chemistry approaches (IUPAC Technical Report). Pure Appl. Chem. 82, 493-504. doi: 10.1351/PAC-REP-09-03-04
71. Lobinski, R., Moulin, C., and Ortega, R. (2006). Imaging and speciation of trace elements in biological environment. Biochimie 88, 1591-1604. doi: 10.1016/j.biochi.2006.10.003
72. Malucelli, E., Iotti, S., Fratini, M., Marraccini, C., Notargiacomo, A., and Gianoncelli, A. (2013). X-ray fluorescence microscopy of light elements in cells: self-absorption correction by integration of compositional and morphological measurements. J. Phys. Conf. Ser. 463:012022. doi: 10.1088/1742-6596/463/1/012022
73. Markesbery, W. R., Ehmann, W. D., Candy, J. M., Ince, P. G., Shaw, P. J., Tandon, L.,et al. (1995). Neutron activation analysis of trace elements in motor neuron disease spinal cord. Neurodegeneration 4, 383-390. doi: 10.1006/neur.1995.0046
74. McRae, R., Bagchi, P., Sumalekshmy, S., and Fahrni, C. J. (2009). In situ imaging of metals in cells and tissues. Chem. Rev. 109, 4780-4827. doi: 10.1021/cr900223a
75. Meadowcroft, M. D., Connor, J. R., Smith, M. B., and Yang, Q. X. (2009). MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J. Magn. Reson. Imaging 29, 997-1007. doi: 10.1002/jmri.21731
76. Mikhaylova, A., Davidson, M., Toastmann, H., Channell, J. E., Guyodo, Y., Batich, C.,et al. (2005). Detection, identification and mapping of iron anomalies in brain tissue using X-ray absorption spectroscopy. J. R. Soc. Interface 2, 33-37. doi: 10.1098/rsif.2004.0011
77. Miller, L. M., and Dumas, P. (2006). Chemical imaging of biological tissue with synchrotron infrared light. Biochim. Biophys. Acta 1758, 846-857. doi: 10.1016/j.bbamem.2006.04.010
78. Miller, L. M., Wang, Q., Telivala, T. P., Smith, R. J., Lanzirotti, A., and Miklossy, J. (2006). Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J. Struct. Biol. 155, 30-37. doi: 10.1016/j.jsb.2005.09.004
79. Morris, C. M., and Edwardson, J. A. (1994). Iron histochemistry of the substantia nigra in Parkinson's disease. Neurodegeneration 3, 277-282.
80. Morris, C. M., Kerwin, J. M., and Edwardson, J. A. (1994). Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration 3, 267-275.
81. Oakley, A. E., Collingwood, J. F., Dobson, J., Love, G., Perrott, H. R., Edwardson, J. A.,et al. (2007). Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68, 1820-1825. doi: 10.1212/01.wnl.0000262033.01945.9a
82. Obst, M., and Schmid, G. (2014). 3D chemical mapping: application of scanning transmission (soft) X-ray microscopy (STXM) in combination with angle-scan tomography in bio-, geo-, and environmental sciences. Methods Mol. Biol. 1117, 757-781. doi: 10.1007/978-1-62703-776-1_34
83. O'Reilly, J., Douglas, D., Braybrook, J., So, P.-W., Vergucht, E., Garrevoet, J.,et al. (2014). A novel calibration strategy for the quantitative imaging of iron in biological tissues by LA-ICP-MS using matrix-matched standards and internal standardisation. J. Anal. At. Spectrom. doi: 10.1039/C4JA00002A [Epub ahead of print].
84. Ortega, R., Cloetens, P., Deves, G., Carmona, A., and Bohic, S. (2007). Iron storage within dopamine neurovesicles revealed by chemical nano-imaging. PLoS ONE 2:e925. doi: 10.1371/journal.pone.0000925
85. Petiet, A., Delatour, B., and Dhenain, M. (2011). Models of neurodegenerative disease - Alzheimer's anatomical and amyloid plaque imaging. Methods Mol. Biol. 771, 293-308. doi: 10.1007/978-1-61779-219-9_16
86. Popescu, B. F., George, M. J., Bergmann, U., Garachtchenjo, A. V., Kelly, M. E., Mccrea, R. P.,et al. (2009a). Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence. Phys. Med. Biol. 54, 651-663. doi: 10.1088/0031-9155/54/3/012
87. Popescu, B. F., Robinson, C. A., Chapman, L. D., and Nichol, H. (2009b). Synchrotron X-ray fluorescence reveals abnormal metal distributions in brain and spinal cord in spinocerebellar ataxia: a case report. Cerebellum 8, 340-351. doi: 10.1007/s12311-009-0102-z
88. Popescu, B. F., Robinson, C. A., Rajput, A., Rajput, A. H., Harder, S. L., and Nichol, H. (2009c). Iron, copper, and zinc distribution of the cerebellum. Cerebellum 8, 74-79. doi: 10.1007/s12311-008-0091-93
89. Popescu, B. F., Pickering, I. J., George, G. N., and Nichol, H. (2007). The chemical form of mitochondrial iron in Friedreich's ataxia. J. Inorg. Biochem. 101, 957-966. doi: 10.1016/j.jinorgbio.2007.03.004
90. Qin, Z., Caruso, J. A., Lai, B., Matusch, A., and Becker, J. S. (2011). Trace metal imaging with high spatial resolution: applications in biomedicine. Metallomics 3, 28-37. doi: 10.1039/c0mt00048e
91. Ralle, M., and Lutsenko, S. (2009). Quantitative imaging of metals in tissues. Biometals 22, 197-205. doi: 10.1007/s10534-008-9200-9205
92. Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C. S.,et al. (2001). Redox-active iron mediates amyloid-beta toxicity. Free Radic. Biol. Med. 30, 447-450. doi: 10.1016/S0891-5849(00)00494-9
93. Rouault, T. A. (2013). Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat. Rev. Neurosci. 14, 551-564. doi: 10.1038/nrn3453
94. Schenck, J. F., and Zimmerman, E. A. (2004). High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed. 17, 433-445. doi: 10.1002/nbm.922
95. Schrag, M., Mueller, C., Oyoyo, U., Smith, M. A., and Kirsch, W. M. (2011). Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.Prog. Neurobiol. 94, 296-306. doi: 10.1016/j.pneurobio.2011.05.001
96. Schulmann-Choron, N., Chevallier, P., De Ceaurriz, J., and Souleau, C. (2000). Determination of selenium in rat brain by synchrotron radiation X-ray fluorescence. Analusis 28, 316-323. doi: 10.1051/analusis:2000121
97. Segel, D. J., Eliezer, D., Uversky, V., Fink, A. L., Hodgson, K. O., and Doniach, S. (1999). Transient dimer in the refolding kinetics of cytochrome c characterized by small-angle X-ray scattering. Biochemistry 38, 15352-15359. doi: 10.1021/bi991337k
98. Smith, M. A., and Perry, G. (1995). Free radical damage, iron, and Alzheimer's disease. J. Neurol. Sci. 134(Suppl), 92-94. doi: 10.1016/0022-510X(95)00213-L
99. Smith, M. A., Zhu, X., Tabaton, M., Liu, G., Mckeel, D. W. Jr., Cohen, M. L.,et al. (2010). Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 19, 363-372. doi: 10.3233/JAD-2010-1239
100. Szczerbowska-Boruchowska, M., Lankosz, M., Ostachowicz, J., Adamek, D., Krygowska-Wajs, A., Tomik, B.,et al. (2004). Topographic and quantitative microanalysis of human central nervous system tissue using synchrotron radiation. X-Ray Spectrom. 33, 3-11. doi: 10.1002/xrs.674
101. Tomik, B., Chwiej, J., Szczerbowska-Boruchowska, M., Lankosz, M., Wojcik, S., Adamek, D.,et al. (2006). Implementation of X-ray fluorescence microscopy for investigation of elemental abnormalities in amyotrophic lateral sclerosis. Neurochem. Res. 31, 321-331. doi: 10.1007/s11064-005-9030-9036
102. Tribl, F., Asan, E., Arzberger, T., Tatschner, T., Langenfeld, E., Meyer, H. E.,et al. (2009). Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach. Mol. Cell. Proteomics 8, 1832-1838. doi: 10.1074/mcp.M900006-MCP200
103. Ugarte, M., Grime, G. W., Lord, G., Geraki, K., Collingwood, J. F., Finnegan, M. E.,et al. (2012). Concentration of various trace elements in the rat retina and their distribution in different structures. Metallomics 4, 1245-1254. doi: 10.1039/c2mt20157g
104. Uversky, V. N., Li, J., Souillac, P., Millett, I. S., Doniach, S., Jakes, R.,et al. (2002). Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J. Biol. Chem. 277, 11970-11978. doi: 10.1074/jbc.M109541200
105. Uversky, V. N., Yamin, G., Munishkina, L. A., Karymov, M. A., Millett, I. S., Doniach, S.,et al. (2005). Effects of nitration on the structure and aggregation of alpha-synuclein. Brain Res. Mol. Brain Res. 134, 84-102. doi: 10.1016/j.molbrainres.2004.11.014
106. Visanji, N. P., Collingwood, J. F., Finnegan, M. E., Tandon, A., House, E., and Hazrati, L. N. (2013). Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy. J. Parkinsons Dis. 3, 523-537. doi: 10.3233/JPD-130197
107. Williams, S., Zhang, X., Jacobsen, C., Kirz, J., Lindaas, S., Van't Hof, J.,et al. (1993). Measurements of wet metaphase chromosomes in the scanning transmission X-ray microscope. J. Microsc. 170, 155-165. doi: 10.1111/j.1365-2818.1993.tb03335.x
108. Yano, J., Kern, J., Irrgang, K. D., Latimer, M. J., Bergmann, U., Glatzel, P.,et al. (2005). X-ray damage to the Mn4Ca complex in single crystals of photosystem II: a case study for metalloprotein crystallography. Proc. Natl. Acad. Sci. U.S.A. 102, 12047-12052. doi: 10.1073/pnas.0505207102
109. Yoshida, S., Ektessabi, A., and Fujisawa, S. (2001). XANES spectroscopy of a single neuron from a patient with Parkinson's disease. J. Synchrotron Radiat. 8, 998-1000. doi: 10.1107/S0909049500017726
110. Zhang, F., Liu, N., Zhao, X., Zuo, A., Yang, L., Xu, Q.,et al. (2002). Variations of elemental distribution in brain regions of neonatal rats at different iodine intakes.Biol. Trace Elem. Res. 90, 227-237. doi: 10.1385/BTER:90:1-3:227